| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239837A1 Novel murd |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/12/1999 | CA2231728A1 Mray |
| 02/11/1999 | WO1999006583A1 Targeted hsv vectors |
| 02/11/1999 | WO1999006582A1 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
| 02/11/1999 | WO1999006576A1 A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof |
| 02/11/1999 | WO1999006572A1 Synaptojanin isoform |
| 02/11/1999 | WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | WO1999006562A1 Method enabling readministration of aav vector via immunosuppression of host |
| 02/11/1999 | WO1999006561A2 Chemokine receptor ccr8 dna and uses thereof |
| 02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
| 02/11/1999 | WO1999006556A1 Growth differentiation factor-16 |
| 02/11/1999 | WO1999006551A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 02/11/1999 | WO1999006549A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 02/11/1999 | WO1999006547A2 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase |
| 02/11/1999 | WO1999006545A2 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 02/11/1999 | WO1999006544A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 02/11/1999 | WO1999006445A1 Growth differentiation factor-15 |
| 02/11/1999 | WO1999006443A1 Growth differentiation factor, lefty-2 |
| 02/11/1999 | WO1999006442A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
| 02/11/1999 | WO1999006439A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006073A1 Method for the treatment of grafts |
| 02/11/1999 | WO1999006064A1 Method for preventing and treating hearing loss using a neurturin protein product |
| 02/11/1999 | WO1999006063A1 EPO PRIMARY RESPONSE GENE, EPRG3pt |
| 02/11/1999 | WO1999006059A2 Methods and compositions relating to no-mediated cytotoxicity |
| 02/11/1999 | WO1999006055A1 Polynucleotide compositions |
| 02/11/1999 | WO1999006034A1 Coup-tfi directed therapies in the treatment of disease |
| 02/11/1999 | WO1999006026A1 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 02/11/1999 | WO1998049311A3 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298811A1 Method for the treatment of grafts |
| 02/11/1999 | CA2298573A1 Synaptojanin isoform |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2298062A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function |
| 02/11/1999 | CA2298061A1 Polynucleotide compositions |
| 02/11/1999 | CA2297747A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | CA2297490A1 Method enabling readministration of aav vector via immunosuppression of host |
| 02/11/1999 | CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | CA2297157A1 5' ests for secreted proteins expressed in testis and other tissues |
| 02/11/1999 | CA2296809A1 5' ests for secreted proteins identified from brain tissues |
| 02/11/1999 | CA2296398A1 5' ests for secreted proteins expressed in endoderm |
| 02/11/1999 | CA2296394A1 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/11/1999 | CA2225185A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896055A2 Apoptosis inducing protein and gene encoding the same |
| 02/10/1999 | CN1207775A Conditionally replicating viral vectors and their use |
| 02/10/1999 | CN1207774A Method for gene introduction into target cells by retrovirus |
| 02/10/1999 | CN1207771A Methods and compositions for diagnosis and treatment of cancer |
| 02/10/1999 | CN1207769A Tissue-specific and target RNA-specific ribozymes |
| 02/09/1999 | US5869633 Thrombin receptor homolog polynucleotide |
| 02/09/1999 | US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis |
| 02/09/1999 | US5869463 Use of neuro-glial cell lines for transplantation therapy |
| 02/09/1999 | US5869337 Regulated transcription of targeted genes and other biological events |
| 02/09/1999 | US5869306 Gene transfer preparation |
| 02/09/1999 | US5869305 Nucleic acid with adeno-associated virus inverted terminal repeat sequence and 20 basepair d sequence; for replication and assembly into viral particles and/or integration into host genome for gene therapy |
| 02/09/1999 | US5869290 Cayae1 polynucleotides |
| 02/09/1999 | US5869286 Receptor that binds IL-17 |
| 02/09/1999 | US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/09/1999 | US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease |
| 02/09/1999 | US5869254 In vitro splicing non-viral target nucleic acid with another to correct defect; for gene therapy, viricides |
| 02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
| 02/09/1999 | US5869248 Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| 02/09/1999 | US5869230 Gene transfer into the kidney |
| 02/09/1999 | US5869077 Subcutaneously implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete insulin dispersed in biocompatible matrix, surrounded by biocompatible external permselective jacket |
| 02/09/1999 | US5869041 Delivery of bioactive compounds to an organism |
| 02/09/1999 | US5869040 Administering interfering mutant proto-oncogene or oncoprotein to target cell |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | US5869035 Through transfer techniques, cancer cells are engineered to express an epitope which is targeted by natural antibodies causing complement destruction of transformed tumor cells associated with hyperacute xenograft rejection |
| 02/08/1999 | CA2239223A1 Novel rpoa |
| 02/08/1999 | CA2239222A1 Novel rpoa |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
| 02/05/1999 | CA2238673A1 Novel aminopeptidase |
| 02/04/1999 | WO1999005303A1 Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method |
| 02/04/1999 | WO1999005302A1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 02/04/1999 | WO1999005301A1 Gene transfer method with the use of serum-free medium |
| 02/04/1999 | WO1999005300A2 Ghrh expression system and methods of use |
| 02/04/1999 | WO1999005299A1 Methods of using cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy |
| 02/04/1999 | WO1999005294A1 INTRACELLULAR INHIBITORS OF Gq PROTEIN SIGNALING |
| 02/04/1999 | WO1999005289A1 Recombinant lysostaphin analogs |
| 02/04/1999 | WO1999005275A1 Secreted proteins encoded by human chromosome 13 |
| 02/04/1999 | WO1999005272A1 Use of transcription factor brn-3a |
| 02/04/1999 | WO1999005269A2 Transcriptional silencer protein nrf |
| 02/04/1999 | WO1999005258A1 HUMAN Nkx POLYPEPTIDE-ENCODING NUCLEIC ACIDS AND TRANSGENIC ANIMALS DERIVED THEREFROM |